BioCentury | Sep 1, 2018
Politics, Policy & Law

Back to School 2018: A pathway to Biopharma 3.0

...Examples come from UCB S.A. and Novartis AG, as well as new players such as Octave Bioscience Inc....
...U.K. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Novo Nordisk A/S (NYSE:NVO; CSE:NOVO B), Bagsvaerd, Denmark Octave Bioscience Inc....
BioCentury | Jul 20, 2018
Financial News

MS play Octave adds Scangos to board, raises $14M series A

...Multiple sclerosis company Octave Bioscience Inc. (Menlo Park, Calif.) raised $14 million on July 12 in a series...
...$2.5 million in seed funding from three undisclosed angel investors. Octave Bioscience Inc., Menlo Park, Calif. Elizabeth S. Eaton Octave Bioscience Inc....
BioCentury | Jul 13, 2018
Financial News

MS play Octave adds Scangos to board, raises $14M series A

...Multiple sclerosis company Octave Bioscience Inc. (Menlo Park, Calif.) raised $14 million in a series A round led...
Items per page:
1 - 3 of 3
BioCentury | Sep 1, 2018
Politics, Policy & Law

Back to School 2018: A pathway to Biopharma 3.0

...Examples come from UCB S.A. and Novartis AG, as well as new players such as Octave Bioscience Inc....
...U.K. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Novo Nordisk A/S (NYSE:NVO; CSE:NOVO B), Bagsvaerd, Denmark Octave Bioscience Inc....
BioCentury | Jul 20, 2018
Financial News

MS play Octave adds Scangos to board, raises $14M series A

...Multiple sclerosis company Octave Bioscience Inc. (Menlo Park, Calif.) raised $14 million on July 12 in a series...
...$2.5 million in seed funding from three undisclosed angel investors. Octave Bioscience Inc., Menlo Park, Calif. Elizabeth S. Eaton Octave Bioscience Inc....
BioCentury | Jul 13, 2018
Financial News

MS play Octave adds Scangos to board, raises $14M series A

...Multiple sclerosis company Octave Bioscience Inc. (Menlo Park, Calif.) raised $14 million in a series A round led...
Items per page:
1 - 3 of 3